Particle.news
Download on the App Store

NIMS Hyderabad Launches Stem Cell Centre of Excellence With Tulsi Therapeutics

The public–private facility will manufacture clinical‑grade stem cells, with clinical trials pending CDSCO clearance.

Overview

  • Telangana Health Minister C. Damodar Raja Narasimha inaugurated the new stem cell lab at Nizam’s Institute of Medical Sciences in Hyderabad on Monday.
  • The centre was established in collaboration with US‑based Tulsi Therapeutics as part of a technology transfer effort.
  • Leaders said the lab is intended to expand access to advanced regenerative care for government‑hospital patients who face high costs at corporate facilities.
  • Tulsi’s founder said the site will produce clinical‑grade stem cells and plans to seek CDSCO approval to begin regulated trials, initially targeting liver failure.
  • Tulsi reported three years of R&D in Hyderabad, including single‑cell RNA sequencing and rodent studies suggesting reversal of severe liver damage, which remains preclinical.